Effect of intravenous butylscopolamine infusion on urge incontinence.
In the case of a combination of urge incontinence and stress incontinence, operative therapy is not successful without previous treatment. In 73% (58/82) of patients treated with 20 mg Butylscopolamine, a significant lowering of the absolute pressure volume values and a significant elevation of bladder capacity could be demonstrated.
D005260:Female; D006801:Humans; D012602:Scopolamine Derivatives / Q000627:therapeutic use*; D014549:Urinary Incontinence / Q000188:drug therapy*
D012602:Scopolamine Derivatives